Company Update2 Min Read InvestyWise NewsonNovember 13, 2025 Granules India Q2 FY26 Earnings Show Strong Growth in Formulations Granules India reported a robust Q2 FY26, driven by formulations growth in North America and Europe. Sales increased, with EBITDA rising due…
Company Update2 Min Read InvestyWise NewsonNovember 13, 2025 Granules India Q2 FY26 Revenue Up 34% YoY, PAT Rises 34% Granules India announced a strong financial performance for the second quarter of fiscal year 2026 (Jul-Sep). Revenue from operations…
Company Update2 Min Read InvestyWise NewsonNovember 13, 2025 Alkem Laboratories Q2 FY26 Revenue Up 17%, EBITDA Surges 22% Alkem Laboratories announced a strong performance in Q2 FY26, with revenue increasing by 17.2% to ₹40,010 Mn. The company’s EBITDA grew…
Company Update1 Min Read InvestyWise NewsonNovember 13, 2025 Zydus Lifesciences Receives USFDA Approval for Diroximel Fumarate Capsules Zydus Lifesciences has secured tentative approval from the USFDA for Diroximel Fumarate Delayed-Release Capsules, 231 mg. These capsules are…
Board Meeting2 Min Read InvestyWise NewsonNovember 13, 2025 Granules India Acquisition and Financial Results Announcement Granules India has announced the approval of its unaudited financial results for Q2 FY26, the acquisition of optus 1039, GmBH in Germany, and…
Company Results1 Min Read InvestyWise NewsonNovember 13, 2025 Alkem Laboratories Reports 17% Revenue Growth, 22% EBITDA Growth in Q2 FY26 Alkem Laboratories announced a 17% YoY revenue increase to ₹40,010 Mn and a 22% YoY growth in EBITDA to ₹9,208 Mn in Q2 FY26. Domestic sales…
Board Meeting1 Min Read InvestyWise NewsonNovember 13, 2025 Alkem Laboratories Reports Consolidated Financial Results for Q2 2026 Alkem Laboratories has announced its consolidated financial results for Q2 2026. The company reported a total income of ₹41,046.8 million and…
Company Results1 Min Read InvestyWise NewsonNovember 13, 2025 Ipca Laboratories Q2/H1 FY26 Financial Results Show Strong Growth Ipca Laboratories announced unaudited financial results for Q2 and H1 FY26. Standalone net total income increased by 7% to ₹1952.24 crores,…
Company Update1 Min Read InvestyWise NewsonNovember 13, 2025 KSB Limited Strong Q2 Results with 5.4% Sales Increase KSB Limited announced a strong Q2 2025 with sales up 5.4% to ₹649.6 crores. The company secured key contracts, including a ₹53.6 crore export…
Board Meeting2 Min Read InvestyWise NewsonNovember 13, 2025 Ipca Laboratories Reports Strong Q2 & H1 FY26 Financial Performance Ipca Laboratories announced a robust financial performance for Q2 and H1 FY26. Standalone Net Total Income increased by 7% to ₹1952.24 crores.…